Seres Therapeutics, Inc. (MCRB)
16.08
+0.11
(+0.69%)
USD |
NASDAQ |
Jan 14, 16:00
15.96
-0.12
(-0.72%)
After-Hours: 20:00
Seres Therapeutics SG&A Expense (TTM): 44.08M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Altimmune, Inc. | 22.68M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |
| Theriva Biologics, Inc. | 16.21M |
| Oragenics, Inc. | 6.832M |